Revenue Estimates Analysis Zynerba Pharmaceuticals, Inc. (ZYNE)

The Numbers On Zynerba 25% Odds Of Success Potential For 100% Upside

The Numbers On Zynerba 25% Odds Of Success Potential For 100% Upside

ILLEGAL ACTIVITY NOTICE: "Zynerba Pharmaceuticals, Inc".

Shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE) opened at 15.06 on Wednesday. The firm now has a buy rating on the stock.

A number of other equities research analysts also recently issued reports on the stock. About 44,645 shares traded. HC Wainwright set a $30.00 price objective on shares of Zynerba Pharmaceuticals and gave the company a buy rating in a research report on Tuesday. Finally, Zacks Investment Research upgraded shares of Zynerba Pharmaceuticals from a sell rating to a hold rating in a report on Thursday, July 13th. Jefferies maintained it with "Buy" rating and $32 target in Tuesday, December 6 report. Two equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company.

When it comes to the Analysis of a Stock, Price Target plays a vital role.

Zynerba Pharmaceuticals, Inc. closed its last trading session at $14.1 with the gain of 6.81%.

Piermont Capital Management Inc. holds 0.94% of its portfolio in Piper Jaffray Companies for 56,671 shares. The stock has "Buy" rating by Roth Capital on Thursday, March 17. Zynerba Pharme... has $32 highest and $22.0 lowest target. After $-0.60 actual earnings per share reported by Zynerba Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Among 6 analysts covering Zynerba Pharme...

While looking at the Stock's Performance, Zynerba Pharmaceuticals, Inc. now shows a Weekly Performance of -12.75%, where Monthly Performance is -11.26%, Quarterly performance is -29.26%, 6 Months performance is -12.65% and yearly performance percentage is 63.7%. If you are accessing this story on another domain, it was stolen and republished in violation of United States & global copyright & trademark laws. The original version of this story can be read at https://www.thestockobserver.com/2017/08/02/zynerba-pharmaceuticals-inc-nasdaqzyne-pt-set-at-28-00-by-cantor-fitzgerald.html. Also, CFO James E. Fickenscher purchased 5,200 shares of the stock in a transaction that occurred on Friday, May 12th. In a transaction dated December 29, 2016, the shares were bought at an average price of $15.85, giving away a sum of $158,500. Following the purchase, the chief financial officer now owns 12,200 shares in the company, valued at approximately $241,804. The purchase was disclosed in a filing with the SEC, which is available at the SEC website.

In related news, Chairman Armando Anido bought 5,000 shares of the business's stock in a transaction on Monday, May 15th. The shares were purchased at an average price of $19.70 per share, for a total transaction of $98,500.00. Similar statistics are true for the second largest owner, Marshall Wace North America L.P., which owns 468,109 shares of the stock are valued at $6.6 million. The disclosure for this purchase can be found here. Given the stock's recent action, it seemed like a good time to take a closer look at the company's recent data. FNY Managed Accounts LLC bought a new stake in Zynerba Pharmaceuticals during the first quarter valued at about $180,000. Bank of New York Mellon Corp increased its position in shares of Zynerba Pharmaceuticals by 5.5% in the first quarter. Rothschild Investment Corp IL now owns 57,070 shares of the company's stock valued at $968,000 after buying an additional 11,450 shares in the last quarter. Finally, BidaskClub raised Zynerba Pharmaceuticals from a "sell" rating to a "hold" rating in a research note on Wednesday, July 12th. Institutional investors and hedge funds own 31.54% of the company's stock.

In recent action, Zynerba Pharmaceuticals, Inc. The Firm is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet needs.

Recommended News

  • Justin Verlander Reportedly Placed on Revocable Waivers Amid Trade Rumors

    Justin Verlander Reportedly Placed on Revocable Waivers Amid Trade Rumors

    Anthony Fenech of the Detroit Free Press reported on July 20 the Houston Astros had "minimal" talks regarding a Verlander trade. The Detroit Tigers have placed starter Justin Verlander on revocable waivers according to a report by Jerry Crasnick of ESPN.

    Callon Petroleum Company (NYSE:CPE) Stake Cut by Prudential Financial Inc

    The Company focuses on the acquisition and development of unconventional oil and natural gas reserves in the Permian Basin. The Company is engaged in the exploration, development, acquisition and production of oil and natural gas properties.

    ConAgra Foods Inc. (CAG) Stake Increased by Curbstone Financial Management Corp

    It increased, as 57 investors sold CAG shares while 203 reduced holdings. 63 funds opened positions while 214 raised stakes. This repurchase authorization authorizes the company to reacquire up to 6.5% of its shares through open market purchases.
  • Hackers Threaten 'Game of Thrones,' as HBO Confirms Cyberattack

    Hackers Threaten 'Game of Thrones,' as HBO Confirms Cyberattack

    In 2014, Sony was on the receiving end of a devastating hack. Its HBO and Game of Thrones .! Enjoy it & spread the words. Whoever spreads well, we will have an interview with him.
    ValuEngine Downgrades Freeport-McMoran, Inc

    ValuEngine Downgrades Freeport-McMoran, Inc

    FCX's total short interest was 57.67M shares in August as published by FINRA. 99 funds opened positions while 175 raised stakes. Punch & Associates Investment Management Inc decreased Aware Inc Mass (AWRE) stake by 8.15% reported in 2016Q4 SEC filing.
    Zim mothers stop breastfeeding too early

    Zim mothers stop breastfeeding too early

    He said: "Wherever a mother has a baby - in Donegal, Dublin or Roscommon - those supports should be there for the her". Unicef described breastfeeding as critical for the achievement of numerous Sustainable Development Goals (SDGs).
  • Anthony Scaramucci says expletive-laden interview was 'off the record'

    Anthony Scaramucci says expletive-laden interview was 'off the record'

    He said his wife's due date wasn't until August 9, and it wasn't until he was in West Virginia that he knew she was in labor. Ryan Lizza , on the other hand, denied having a personal relationship with the former communications director.
    Sanchez in line for Wembley after return to training

    Sanchez in line for Wembley after return to training

    Arsenal's Chilean superstar has always been one of City's top summer targets but they have been patient in their approach. But the Frenchman has made it clear that Premier League clubs will never be able to sign him.
    Citigroup Inc. Lowers Chesapeake Energy Corporation (CHK) Price Target to $5.00

    Citigroup Inc. Lowers Chesapeake Energy Corporation (CHK) Price Target to $5.00

    A month ago, they told us to expect earnings of US$0.19 per share while three months ago their EPS consensus estimate was US$0.19. Creative Planning holds 203,465 shares or 0.01% of its portfolio. 298,550 were reported by Greylin Investment Mangement Inc.
  • Nacional clasificó a cuartos de final de la Sudamericana ante Olimpia

    Nacional clasificó a cuartos de final de la Sudamericana ante Olimpia

    Nacional enfrentará en su próximo compromiso al ganador de la serie entre el argentino Estudiantes de la Plata y el boliviano Nacional Potosí, cuya decisión será mañana en Buenos Aires.

    "Ho fatto il massimo contro Ferrari superiori a noi" — Bottas

    Il pilota britannico ha così 'perso' tre punti, andando a -14 dal leader Sebastian Vettel . Mi auguro di non perdere il titolo per questi punti.
    Standard Chartered slides on lack of dividend payout

    Standard Chartered slides on lack of dividend payout

    As at June 30, Standard Chartered's Common Equity Tier 1 ratio stood at 13.8%, rising from 13.6% at the end of 2016. Shares in the lender were the biggest faller on the FTSE 100, dropping more than 5 per cent in early...

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.